CAAS
WST icon

Capital Asset Advisory Services’s West Pharmaceutical WST Stock Holding History

Capital Asset Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-831
Closed -$251K – 592
2022
Q2 		$251K Buy
831
+90
+12% +$29.3K 0.03% 342
2022
Q1 		$304K Buy
741
+208
+39% +$81.4K 0.03% 327
2021
Q4 		$250K Sell
533
-19
-3% -$8.18K 0.03% 352
2021
Q3 		$234K Sell
552
-14
-2% -$5.9K 0.03% 388
2021
Q2 		$203K Buy
+566
New +$187K 0.02% 428
2021
Q1 		– Sell
-307
Closed -$87K – 1514
2020
Q4 		$87K Buy
+307
New +$86.1K 0.02% 490

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return